SLC5A2 and type 2 diabetes mellitus: Sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) is an oral hypoglycemicdrug, which has been shown to effectively control blood sugar in patients withtype 2 diabetes mellitus (T2DM) [4].